Literature DB >> 12131054

Informed decision-making on sympathomimetic use in sport and health.

Ron Bouchard1, Anna R Weber, Jonathan D Geiger.   

Abstract

The International Olympic Committee, the World Anti-Doping Agency, and International Sport Federations have banned and restricted the use of many stimulants including prescription and over-the-counter medications and dietary supplements. In addition to elite athletes, people of all ages use stimulants in attempts to improve athletic performance, alter body composition, and increase levels of energy. Here we introduce a seven-stage model designed to facilitate informed decision-making by individuals taking or thinking of taking stimulants for sport, health, and/or appearance reasons. We review for amphetamines, over-the counter sympathomimetics, and caffeine their performance-enhancing and performance-degrading effects, health benefits and mechanisms of action, medical side effects, and legal, ethical, safety, and financial implications.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12131054     DOI: 10.1097/00042752-200207000-00003

Source DB:  PubMed          Journal:  Clin J Sport Med        ISSN: 1050-642X            Impact factor:   3.638


  5 in total

1.  Proposed actions for the US Food and Drug Administration to implement to minimize adverse effects associated with energy drink consumption.

Authors:  Janet Thorlton; David A Colby; Paige Devine
Journal:  Am J Public Health       Date:  2014-05-15       Impact factor: 9.308

2.  Effect of ambient temperature on caffeine ergogenicity during endurance exercise.

Authors:  Matthew S Ganio; Evan C Johnson; Jennifer F Klau; Jeffrey M Anderson; Douglas J Casa; Carl M Maresh; Jeff S Volek; Lawrence E Armstrong
Journal:  Eur J Appl Physiol       Date:  2010-12-01       Impact factor: 3.078

Review 3.  Caffeine and ephedrine: physiological, metabolic and performance-enhancing effects.

Authors:  Faidon Magkos; Stavros A Kavouras
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

4.  Attention deficit hyperactivity disorder and athletes.

Authors:  Russell D White; George D Harris; Margaret E Gibson
Journal:  Sports Health       Date:  2014-03       Impact factor: 3.843

5.  Metabolic Profiling of Systemic Lupus Erythematosus and Comparison with Primary Sjögren's Syndrome and Systemic Sclerosis.

Authors:  Anders A Bengtsson; Johan Trygg; Dirk M Wuttge; Gunnar Sturfelt; Elke Theander; Magdalena Donten; Thomas Moritz; Carl-Johan Sennbro; Frida Torell; Christian Lood; Izabella Surowiec; Stefan Rännar; Torbjörn Lundstedt
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.